A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

✍ Scribed by Michael B. Jameson; Danny Rischin; Mark Pegram; John Gutheil; Adam V. Patterson; William A. Denny; William R. Wilson

• Book ID: 105993329
• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 303 KB
• Volume: 65
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-1188-1